We recently published a list of 10 Best Dividend Kings Stocks to Invest in Now. In this article, we are going to take a look ...

CL's solid pricing strategies and premium innovation drive growth, but macroeconomic challenges and currency headwinds ...

Stifel Nicolaus analyst Mark Astrachan maintained a Hold rating on Colgate-Palmolive (CL – Research Report) today and set a price target of ...

In a report released on January 15, Nik Modi from RBC Capital maintained a Hold rating on Colgate-Palmolive (CL – Research Report), with a ...

Pallas Capital Advisors LLC lowered its position in Colgate-Palmolive (NYSE:CL – Free Report) by 6.6% in the 4th quarter, ...

Colgate-Palmolive Co. closed $22.20 short of its 52-week high ($109.30), which the company reached on September 5th.

Colgate-Palmolive (NYSE:CL – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the twenty-two ...

Fluoride helps prevent cavities when applied topically to the teeth, but when ingested can pose significant risks, even kill ...

Colgate-Palmolive Co (CL) stock saw a modest uptick, ending the day at $88.56 which represents a slight increase of $0.70 or 0.80% from the prior close of $87.86. The stock opened at $87.6 and touched ...

Stifel highlighted that Colgate's Hill's pet nutrition brand continues to be a strong growth driver for the company. In the fourth quarter of 2024, Hill's achieved a remarkable 25% growth, with the ...

There is more to the comparison, and in the sections below, we discuss why we think CL will outperform KMB in the next three ...

Procter & Gamble and Colgate-Palmolive are among the defendants in six new lawsuits targeting the sale of toothpaste and ...